ACL — Australian Clinical Labs Share News
0.000.00%
Last trade - 00:00- AU$529.23m
- AU$841.21m
- AU$735.75m
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million
Australian Clinical Labs drops after cyber incident update
Brief: Australian Clinical Labs Gives Update On Third-Party Cyber Incident Impacting Sundoctors
Australian Clinical Labs says limited data taken in SunDoctors cyberattack
Brief: Australian Clinical Labs Appoints Greg Horan As Group CEO
Australian Clinical Labs hits record low after cyber attack
Brief: Australian Clinical Labs Says External IT Service Provider For Sundoctors Experiences Cyber Incident
Brief: Australian Clinical Labs Served With Representative Proceeding
Australian Clinical Labs slips on alleged consumer law breaches
Australian Clinical Labs slips to record low on half-year profit drop profit drop
Brief: Australian Clinical Labs Group CEO Melinda Mcgrath Confirms Will Not Be Renewing Contract
Brief: Australian Clinical Labs Announces FY2026 Interim Dividend Of 3.75 AU CPS
Brief: Australian Clinical Labs Sees FY26 Revenue A$735M - A$745M
Australia's Optiscan Imaging rises on deal with Australian Clinical Labs
Brief: Australian Clinical Labs Announces On Market Share Buy Back
Australian Clinical Labs hits seven-week high on share buyback